BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 27221715)

  • 1. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.
    Bulian P; Shanafelt TD; Fegan C; Zucchetto A; Cro L; Nückel H; Baldini L; Kurtova AV; Ferrajoli A; Burger JA; Gaidano G; Del Poeta G; Pepper C; Rossi D; Gattei V
    J Clin Oncol; 2014 Mar; 32(9):897-904. PubMed ID: 24516016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
    Majid A; Lin TT; Best G; Fishlock K; Hewamana S; Pratt G; Yallop D; Buggins AG; Wagner S; Kennedy BJ; Miall F; Hills R; Devereux S; Oscier DG; Dyer MJ; Fegan C; Pepper C
    Leuk Res; 2011 Jun; 35(6):750-6. PubMed ID: 21093051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
    Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.
    Ibrahem L; Elderiny WE; Elhelw L; Ismail M
    Blood Cells Mol Dis; 2015 Aug; 55(2):154-60. PubMed ID: 26142332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic significance of new biological markers in chronic lymphocytic leukaemia].
    Leković D; Mihaljević B; Kraguljac-Kurtović N; Perunčić-Jovanović M; Bogdanović A; Čolović M; Gotić M
    Srp Arh Celok Lek; 2011; 139(11-12):753-8. PubMed ID: 22338471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
    Brachtl G; Piñón Hofbauer J; Greil R; Hartmann TN
    Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
    Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
    Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.
    Hus I; Podhorecka M; Bojarska-Junak A; Roliński J; Schmitt M; Sieklucka M; Wasik-Szczepanek E; Dmoszyńska A
    Ann Oncol; 2006 Apr; 17(4):683-90. PubMed ID: 16524977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
    Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA
    Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
    Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
    Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of ZAP-70 protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma].
    Qi RJ; Zhang PH; Qiu LG; Fang LH; Yang QY; Sun FJ; Chen HS
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):329-32. PubMed ID: 19575876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.